Clinical Trials and Preclinical Infrastructure Asset Map - Life Sciences

86
BRITISH COLUMBIA
Multiple Sclerosis Clinic
The Multiple Sclerosis Clinic (www.ubcneurology.com/Research_MS.html) operates at UBC Hospital.
It had 3,698 patient visits and 635 new patients in 2007. The clinic coordinates new escalating therapy
options for aggressive MS and also provides specialized care for neuromyelitis optica (NMO). It provides
outreach support to clinics in Victoria (1,000 patients registered), Kelowna (700 patients), and Prince
George (300 patients), as well as providing outreach care directly to patients in Comox (Vancouver
Island).
Therapeutic trials in MS have encompassed both disease modifying and symptomatic therapies. All
stages and types of MS have been represented in at least Phases II and III trials. Investigators have a
strong profile in clinical trial development, safety monitoring and MRI/immunology sub-studies. The
MS/MRI Research Group has provided central analysis for numerous international multicentre randomized
clinical trials and are recognized internationally for their work in this area.
The Clinic’s seven neurologist investigators are as follows, with details contained in Appendix 6:
• Devonshire, Virginia • Oger, Joel
• Hashimoto, Stanley • Rieckmann, Peter
• Hooge, John
• Traboulsee, Anthony
• Kastrukoff, Lorne
Contact:
Traboulsee, A. Head of Clinical Trials Group. Tel: 604 822-0788. trabouls@interchange.ubc.ca.
Pacific Parkinson’s Research Centre
Located at UBC Hospital, the Pacific Parkinson’s Research Centre is a multidisciplinary program dedicated
to the diagnosis and management of Parkinson’s and other related disorders, such as tremor and
dystonia (www.parkinsons.ubc.ca/index.html). It has been designated as a Centre of Excellence by the
National Parkinson Foundation in the US. In addition to treating patients, it has a strong research program
that spans preclinical, clinical and population studies. Under the direction of Dr. Jonathan Stoessl,
an internationally recognized expert on Parkinson’s disease, the centre has the largest peer-reviewed
research program in Canada on Parkinson’s disease.
The Centre has three neurologists (listed below), whose details can be found in Appendix 6.
• McKeown, Martin J.
• Stoessl, Jonathan
• Tsui, Joseph
These investigators conduct trials involving novel drugs, surgery, and neuroimaging. Patients registered
with the UBC Movement Disorders Clinic in 2007 included 1,100 with typical Parkinson’s disease, 400
patients with Parkinson-like disorders, and 500 – 1,000 with dystonia 5 .
The Centre also has a clinical trials coordinator. It conducts Phases I, II, III, and IV studies.
Contact:
Babul, Shamin. Administrator. Tel: 604-822-7721. ndsb@interchange.ubc.ca.